Henry Schein Inc

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 8.86 B
Employee 25 K
Founded N/A
CEO Stanley M. Bergman
Website www.henryschein.com
Headquarter Delaware, United States
FIGI BBG000BNMMJ3
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

8.86 B Capitalizzazione di mercato

Rapporto prezzo/utili

23.38

Rapporto prezzo/fatturato

0.71

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world’s largest provider of health care solutions to office-based dental and medical practitioners.

HSIC

Financials

Henry Schein Inc

Notizie

Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term

What to Expect From Henry Schein’s Q1 2026 Earnings Report

Il CdA di Henry Schein si ridurrà a 10 membri dopo l’assemblea annuale

Should You Retain Henry Schein Stock in Your Portfolio for Now?

ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?

Align Technology: Only International Growth Can Save Them Now (Downgrade) (NASDAQ:ALGN)

I migliori titoli di tecnologia medica secondo Piper Sandler

Henry Schein alla Conferenza Barclays: espansione digitale e guadagni di mercato

Henry Schein at Barclays Conference: Digital Expansion and Market Gains

Henry Schein, Inc. (HSIC) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Leerink Partners conferma il rating su Henry Schein con target a $87

Leerink Partners reiterates Henry Schein stock rating at $87 target